Free CME from PeerView


Hematology CME

Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
The Bedrock of Personalized NF1 Care: Fundamentals of Managing NF1-Associated PNs and Other Tumors With Innovative Targeted Therapy
Laura Klesse, MD, PhD / Carlos G. Romo, MD
May 10, 2023
Credits: 1.5 NCPD / ILNA
PVI, PeerView Institute for Medical Education
Betting on BCMA in Multiple Myeloma: Oncology Nurse Principles for Delivering Effective Care With BCMA Antibodies and Cellular Therapy
Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO
April 28, 2023
Credits: 1.5 NCPD / ILNA
PVI, PeerView Institute for Medical Education
Leading Change, Leading Advances in CLL Care: Guidance on Delivering Modern Targeted and Cellular Therapeutics
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
April 27, 2023
Credits: 1.0 CPE
PVI, PeerView Institute for Medical Education
Coordinating Better Outcomes in Multiple Myeloma: Pharmacist Leadership With Novel Antibodies and CAR-T Therapy
R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA / Zahra Mahmoudjafari, PharmD, MBA, BCOP
April 14, 2023
Credits: 1.0 CME / MOC / CPE / IPCE
PVI, PeerView Institute for Medical Education
Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effective Care With Targeted Therapy
Emily K. Dotson, PharmD, BCOP
March 31, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
Overcoming GVHD Is the Key to Better HCT Outcomes: Guidance on Managing Acute and Chronic Disease
Stephanie Lee, MD, MPH
March 22, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
The Time Is Now for Outpatient CAR-T: Essential Infrastructure, Lessons From Transplant, and New Evidence
Olalekan Oluwole, MBBS, MD
March 16, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Shaping Modern Management of Myelofibrosis: Guidance on the Conjunction of Targeted Therapy and AlloHCT
Aaron T. Gerds, MD, MS / John Mascarenhas, MD
March 16, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
The Convergence of Innovative Therapy and AlloHCT in AML: Applying Current Evidence to Improve Outcomes
James M. Foran, MD, FRCPC / Jessica K. Altman, MD
March 14, 2023
Credits: 1.0 CME
Medical Learning Institute, Inc.
"House Rules" for Innovative Therapy in Multiple Myeloma: Guidance on Integrating Monoclonal Antibodies and BCMA and Non-BCMA Options Into Patient Care
Robert Z. Orlowski, MD, PhD
March 14, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
Finding Treatment Synergy in CLL: Expert Consults on Advances With Targeted and Cellular Therapy
Mazyar Shadman, MD, MPH / Peter A. Riedell, MD
March 13, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
New Rules for VOD/SOS: Modern Risk Assessment, Diagnostic Principles, and Innovative Treatment
Prof. Mohamad Mohty / Christine N. Duncan, MD
March 13, 2023
Credits: 1.5 CME / CC
PVI, PeerView Institute for Medical Education
The Precision Team in AML: Exploring Pathologist-Informed Clinical Decisions in Challenging AML Settings
Naval Daver, MD / Joseph D. Khoury, MD, FCAP
March 13, 2023
Credits: 1.0 CME / MOC / CC
PVI, PeerView Institute for Medical Education
Seizing the Precision Care Moment in MDS: Collaborative Strategies for Accurate Diagnoses and Risk-Adapted Treatment
Rami Komrokji, MD
March 13, 2023
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Real-World Challenges and Solutions with BTKi in CLL: Therapeutic Insights for Community Practice
Jennifer Woyach, MD
March 06, 2023
Credits: 0.25 CME / NCPD / ILNA
PVI, PeerView Institute for Medical Education
Real-World Nursing Solutions for AML Care: Insights on the Effective and Safe Delivery of Innovative Therapeutics
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
February 28, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
Hitting the BCMA Target in Multiple Myeloma: Insights on CAR-T Therapy and Innovative Antibody Options
Thomas G. Martin, III, MD / Krina Patel, MD, MSc
February 15, 2023
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
Innovation Now for Follicular Lymphoma: New Evidence for Immunotherapy, Targeted, and Chemo-Free Options
Loretta J. Nastoupil, MD
February 02, 2023
Credits: 0.75 CME / MOC
PVI, PeerView Institute for Medical Education
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
John C. Byrd, MD
February 02, 2023
Credits: 1.0 CME / MOC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Building a Safety-Centric Culture in B-Cell Cancers: Interprofessional Insights on Optimizing BTKi Efficacy Through Safety Management
Nicole Lamanna, MD
January 31, 2023
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Changing Times for Hemophilia: Exploring Evidence With Novel and Emerging Nonfactor Therapies
Steven W. Pipe, MD
December 30, 2022
Credits: 1.25 CPE
Purdue University College of Pharmacy
Novel Strategies for Managing Patients With CKD-Associated Anemia: What Do Health-System Pharmacists Need to Know About HIF-PH Inhibitors?
Jay B. Wish, MD
December 21, 2022
Credits: 1.25 CME / MOC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Critical Conversations on Venous Thromboembolism: A MasterClass Series on DVT and PE
Alexander (Ander) T. Cohen, MBBS, MSc, MD, FRACP, FESC, FRCP
December 16, 2022
Credits: 1.5 CME / MOC
PSU, Penn State University
The Rising Tide of CAR-T in Lymphoma: Guidance on Leveraging Cellular Therapy to Improve Outcomes Across the Spectrum of Care
Jason Westin, MD, MS, FACP
December 09, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
The Winning Way With BTK Inhibitors in CLL: Evidence-Informed Choices on Treatment Selection, Safety, and Therapeutic Sequencing
John C. Byrd, MD
December 09, 2022
Credits: 2.0 CME / MOC
Medical Learning Institute, Inc.
The Road to Remission in Multiple Myeloma: Expert Guidance on Using BCMA-Targeted Options to Enhance Clinical Outcomes
Nikhil C. Munshi, MD
December 09, 2022
Credits: 1.5 CME / MOC
PSU, Penn State University
The Future is Now in MDS: Integrating Innovative, Risk-Adapted Therapies Into Patient Management
Guillermo Garcia-Manero, MD
December 09, 2022
Credits: 2.0 CME / MOC
PSU, Penn State University
Fine-Tuning the Wave of Innovation in CLL: Personalized Models for Upfront and Sequential Care With Groundbreaking Treatment
Prof. John G. Gribben, MD, DSc
December 09, 2022
Credits: 1.5 CME / MOC
Penn State College of Medicine
Real-World, Real Innovation in DLBCL: Perspectives on Integrating Novel Antibody Platforms Into Patient Care
Grzegorz (Greg) Nowakowski, MD
December 09, 2022
Credits: 1.25 CME
Medical Learning Institute, Inc.
Demystifying Cold Agglutinin Disease: A Visual Exploration of Mechanism, Diagnosis, and the Role of Complement Inhibition in Addressing Unmet Needs
Sigbjørn Berentsen, MD, PhD / Ilene C. Weitz, MD
December 09, 2022

Pages

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView